Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > UAlbany NanoCollege Names Medical Expert to Spearhead New NanoHealth Initiative

The first physician to join the CNSE faculty, Dr. Sara Brenner will coordinate a new CNSE initiative to explore and apply nanotechnology innovations in health and safety applications

UAlbany NanoCollege Names Medical Expert to Spearhead New NanoHealth Initiative

Albany, NY | Posted on August 6th, 2009

The College of Nanoscale Science and Engineering ("CNSE") of the University at Albany announced today that it has selected an accomplished physician to head a next-generation NanoHealth initiative that will focus on education, research, and deployment of nanotechnology enabled improvements in occupational, public, and environmental health and safety.

As CNSE Assistant Vice President for NanoHealth Initiatives and Assistant Professor of Nanobioscience, Dr. Sara Brenner will spearhead leading-edge research aimed at developing novel nanotechnology applications in nanomedicine, including nanotoxicology and environmental and public health. She will also lead health and safety research initiatives related to nanoparticle and nanomaterial exposures in the workplace, consumer marketplace, and the environment.

The first physician to join the faculty of the UAlbany NanoCollege, Dr. Brenner is providing medical expertise for CNSE's nanomedicine initiatives, including projects in cancer research and regenerative medicine, such as tissue engineering and artificial organs; designing a first-of-its-kind nanotoxicology program; and exploring the creation of a groundbreaking clinical scientist training program in nanomedicine.

Her research will also seek to establish a systematic understanding of the health and safety implications and effects associated with the unique characteristics of nanoparticles, with a focus on assessing and mitigating risk, developing reduction strategies for occupational exposures, improving the monitoring of nanoparticles that may impact public and environmental health, and recommending industrial practice standards for product safety.

George Philip, President of the University at Albany, said, "Already recognized as the world leader in pioneering nanotechnology education and game-changing nanoscale science and engineering research, the College of Nanoscale Science and Engineering is once again breaking important new ground with the addition of Dr. Brenner to CNSE's world-class faculty. Her demonstrated expertise, in combination with CNSE's unparalleled excellence, will enable exciting new advances in 21st century health care and environmental safety, while serving to bolster the University's global recognition as one of the world's preeminent research universities."

Alain E. Kaloyeros, Ph.D., Senior Vice President and Chief Executive Officer of CNSE, said, "I am delighted to welcome Dr. Brenner to the UAlbany NanoCollege, where she will lead the creation of a first-of-its-kind NanoHealth initiative that is as pioneering as it is important. Known for her keen intellect, contagious energy, comprehensive knowledge, and responsible ethics, Sara brings a distinctive perspective to the exciting field of nanobioscience that is seamlessly suited to the CNSE pioneering interdisciplinary paradigm, particularly for advancing preventive and therapeutic innovations in health care."

Professor Brenner said, "I am thrilled to have the opportunity to join the world-class faculty at the College of Nanoscale Science and Engineering, and particularly to have the chance to design and implement a groundbreaking and vital NanoHealth program. In applying nanotechnology to the critical areas of disease prevention, early detection, monitoring and treatment, we plan to effectively translate nanoscale innovations into practical solutions that will drastically improve 21st century health care and public safety. I look forward to the establishment of an integrated health sciences partnership with top flight medical institutions and leading health and safety public agencies in the Capital Region and across New York State."

Professor Brenner received her B.S. in genetics from Iowa State University, her M.D. from the University of Iowa's Carver College of Medicine, and her M.P.H. from the University at Albany's School of Public Health. Among numerous awards and honors, she has received the American College of Preventive Medicine's Don Gemson Resident Award; the A. Zamin Rizavi, M.D. Internal Medicine Award; the University of Iowa Hancher-Finkbine Medallion; the American Medical Association's Foundation Leadership Award; and the American College of Preventive Medicine's Future Leaders in Preventive Medicine Award.

The American Society for Nanomedicine (ASNM) and the National Institutes of Health (NIH) define nanomedicine as the application of nanoscale scientific concepts and engineering principles to medical diagnosis, monitoring, and treatment "at the level of single molecules or molecular assemblies that provide structure, control, signaling, homeostasis and motility in cells." As such, nanomedicine, "an offshoot of nanotechnology," involves "highly specific medical interventions at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve."

Nanomedicine holds the promise for truly innovative, leading edge, preventive treatments and effective cures. Potential applications, as cited by the NIH, include nanoscale tools that enable doctors to "search out and destroy the very first cancer cells that would otherwise have caused a tumor to develop in the body;" molecularly precise procedures that can remove a broken part of a cell and replace it with a miniature biological machine; and pumps the size of molecules that could be implanted to deliver life-saving medicines precisely when and where they are needed. The NIH also predicts that nanomedicine will enable the development of "new tools that will work at the nanoscale and allow scientists to build synthetic biological devices, such as tiny sensors to scan for the presence of infectious agents or metabolic imbalances that could spell trouble for the body, and miniature devices to destroy the infectious agents or fix damaged cellular parts."


About UAlbany NanoCollege
The UAlbany CNSE is the first college in the world dedicated to education, research, development, and deployment in the emerging disciplines of nanoscience, nanoengineering, nanobioscience, and nanoeconomics. CNSE's Albany NanoTech Complex is the most advanced research enterprise of its kind at any university in the world. With over $5 billion in high-tech investments, the 800,000-square-foot complex attracts corporate partners from around the world and offers students a one-of-a-kind academic experience. The UAlbany NanoCollege houses the only fully-integrated, 300mm wafer, computer chip pilot prototyping and demonstration line within 80,000 square feet of Class 1 capable cleanrooms. More than 2,500 scientists, researchers, engineers, students, and faculty work on site at CNSE's Albany NanoTech, from companies including IBM, AMD, GlobalFoundries, SEMATECH, Toshiba, Applied Materials, Tokyo Electron, ASML, Novellus Systems, Vistec Lithography and Atotech.

For more information, please click here

Steve Janack, CNSE Vice President for Marketing and Communications
Phone: 518-956-7322

Copyright © UAlbany NanoCollege

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Unusual quantum liquid on crystal surface could inspire future electronics October 22nd, 2016

Physicists use lasers to capture first snapshots of rapid chemical bonds breaking October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

New perovskite solar cell design could outperform existing commercial technologies: Stanford, Oxford team creates high-efficiency tandem cells October 21st, 2016


The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

New Agricultural Research Center Debuts at UCF October 12th, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016


Nanosciences: Genes on the rack October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

Tiny gold particles could be the key to developing a treatment for pancreatic cancer October 19th, 2016

Highly conductive and pure gold nanostructures grown by electron beam induced deposition October 17th, 2016


Unusual quantum liquid on crystal surface could inspire future electronics October 22nd, 2016

Nanosciences: Genes on the rack October 21st, 2016

Physicists use lasers to capture first snapshots of rapid chemical bonds breaking October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

Appointments/Promotions/New hires/Resignations/Deaths

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016

Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016

GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project